Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Selliah, N; Finkel, TH
   Biochemical mechanisms of HIV induced T cell apoptosis
   CELL DEATH AND DIFFERENTIATION
   
   N. Selliah e T.H. Finkel, "Biochemical mechanisms of HIV induced T cell apoptosis", CELL DEAT D, 8(2), 2001, pp. 127-136
2. Park, D; Yun, Y
   Tyrosine phosphorylation-dependent yeast two-hybrid system for the identification of the SH2 domain-binding proteins
   MOLECULES AND CELLS
   
   D. Park e Y. Yun, "Tyrosine phosphorylation-dependent yeast two-hybrid system for the identification of the SH2 domain-binding proteins", MOL CELLS, 12(2), 2001, pp. 244-249
3. Kunjibettu, S; Fuller-Espie, S; Carey, GB; Spain, LM
   Conserved transmembrane tyrosine residues of the TCR beta chain are required for TCR expression and function in primary T cells and hybridomas
   INTERNATIONAL IMMUNOLOGY
   
   S. Kunjibettu et al., "Conserved transmembrane tyrosine residues of the TCR beta chain are required for TCR expression and function in primary T cells and hybridomas", INT IMMUNOL, 13(2), 2001, pp. 211-222
4. Morley, SCP; Bierer, BE
   The actin cytoskeleton, membrane lipid microdomains, and T cell signal transduction
   ADVANCES IN IMMUNOLOGY, VOL 77
   
   S.C.P. Morley e B.E. Bierer, "The actin cytoskeleton, membrane lipid microdomains, and T cell signal transduction", ADV IMMUNOL, 77, 2001, pp. 1-43
5. Lagunoff, M; Lukac, DM; Ganem, D
   Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: Effects on lytic viral replication
   JOURNAL OF VIROLOGY
   
   M. Lagunoff et al., "Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: Effects on lytic viral replication", J VIROLOGY, 75(13), 2001, pp. 5891-5898
6. Andersen, MH; Keikavoussi, P; Brocker, EB; Schuler-Thurner, B; Jonassen, M; Sondergaard, I; Straten, PT; Becker, JC; Kampgen, E
   Induction of systemic CTL responses in melanoma patients by dendritic cellvaccination: Cessation of CTL responses is associated with disease progression
   INTERNATIONAL JOURNAL OF CANCER
   
   M.H. Andersen et al., "Induction of systemic CTL responses in melanoma patients by dendritic cellvaccination: Cessation of CTL responses is associated with disease progression", INT J CANC, 94(6), 2001, pp. 820-824
7. Kono, K; Takahashi, A; Iizuka, H; Fujii, H; Sekikawa, T; Matsumoto, Y
   Effect of oesophagectomy on monocyte-induced apoptosis of peripheral bloodT lymphocytes
   BRITISH JOURNAL OF SURGERY
   
   K. Kono et al., "Effect of oesophagectomy on monocyte-induced apoptosis of peripheral bloodT lymphocytes", BR J SURG, 88(8), 2001, pp. 1110-1116
8. Lieberman, J; Shankar, P; Manjunath, N; Andersson, J
   Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection
   BLOOD
   
   J. Lieberman et al., "Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection", BLOOD, 98(6), 2001, pp. 1667-1677
9. Krishnan, S; Warke, VG; Nambiar, MP; Wong, HK; Tsokos, GC; Farber, DL
   Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3 zeta expression
   BLOOD
   
   S. Krishnan et al., "Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3 zeta expression", BLOOD, 97(12), 2001, pp. 3851-3859
10. Radoja, S; Frey, AB
    Cancer-induced defective cytotoxic T lymphocyte effector function: Anothermechanism how antigenic tumors escape immune-mediated killing
    MOLECULAR MEDICINE
    
    S. Radoja e A.B. Frey, "Cancer-induced defective cytotoxic T lymphocyte effector function: Anothermechanism how antigenic tumors escape immune-mediated killing", MOL MED, 6(6), 2000, pp. 465-479
11. Tsokos, GC; Wong, HK; Enyedy, EJ; Nambiar, MP
    Immune cell signaling in lupus
    CURRENT OPINION IN RHEUMATOLOGY
    
    G.C. Tsokos et al., "Immune cell signaling in lupus", CURR OP RH, 12(5), 2000, pp. 355-363
12. Tamura, T; Kunimatsu, T; Yee, ST; Igarashi, O; Utsuyama, M; Tanaka, S; Miyazaki, S; Hirokawa, K; Nariuchi, H
    Molecular mechanism of the impairment in activation signal transduction inCD4(+) T cells from old mice
    INTERNATIONAL IMMUNOLOGY
    
    T. Tamura et al., "Molecular mechanism of the impairment in activation signal transduction inCD4(+) T cells from old mice", INT IMMUNOL, 12(8), 2000, pp. 1205-1215
13. Fais, S; Luciani, F; Logozzi, M; Parlato, S; Lozupone, F
    Linkage between cell membrane proteins and actin-based cytoskeleton: the cytoskeletal-driven cellular functions
    HISTOLOGY AND HISTOPATHOLOGY
    
    S. Fais et al., "Linkage between cell membrane proteins and actin-based cytoskeleton: the cytoskeletal-driven cellular functions", HIST HISTOP, 15(2), 2000, pp. 539-549
14. Ilangumaran, S; He, HT; Hoessli, DC
    Microdomains in lymphocyte signalling: beyond GPI-anchored proteins
    IMMUNOLOGY TODAY
    
    S. Ilangumaran et al., "Microdomains in lymphocyte signalling: beyond GPI-anchored proteins", IMMUNOL TOD, 21(1), 2000, pp. 2-7
15. Clavreul, A; Fisson, S; D'hellencourt, CL; Couez, D
    Interelationship between CD3 and CD28 pathways in a murine T cell thymoma
    MOLECULAR IMMUNOLOGY
    
    A. Clavreul et al., "Interelationship between CD3 and CD28 pathways in a murine T cell thymoma", MOL IMMUNOL, 37(10), 2000, pp. 571-577
16. Farrar, MA; Olson, SH; Perlmutter, RM
    Coumermycin-induced dimerization of GyrB-containing fusion proteins
    APPLICATIONS OF CHIMERIC GENES AND HYBRID PROTEINS PT B
    
    M.A. Farrar et al., "Coumermycin-induced dimerization of GyrB-containing fusion proteins", METH ENZYM, 327, 2000, pp. 421-429
17. Krummel, MF; Sjaastad, MD; Wulfing, C; Davis, MM
    Differential clustering of CD4 and CD3 zeta during T cell recognition
    SCIENCE
    
    M.F. Krummel et al., "Differential clustering of CD4 and CD3 zeta during T cell recognition", SCIENCE, 289(5483), 2000, pp. 1349-1352
18. Trimble, LA; Shankar, P; Patterson, M; Daily, JP; Lieberman, J
    Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3 zeta and CD28, key signaling molecules for T-cell activation
    JOURNAL OF VIROLOGY
    
    L.A. Trimble et al., "Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3 zeta and CD28, key signaling molecules for T-cell activation", J VIROLOGY, 74(16), 2000, pp. 7320-7330
19. Kataoka, T; Yamada, A; Bando, M; Honma, T; Mizoue, K; Nagai, K
    FD-891, a structural analogue of concanamycin A that does not affect vacuolar acidification or perforin activity, yet potently prevents cytotoxic T lymphocyte-mediated cytotoxicity through the blockage of conjugate formation
    IMMUNOLOGY
    
    T. Kataoka et al., "FD-891, a structural analogue of concanamycin A that does not affect vacuolar acidification or perforin activity, yet potently prevents cytotoxic T lymphocyte-mediated cytotoxicity through the blockage of conjugate formation", IMMUNOLOGY, 100(2), 2000, pp. 170-177
20. Chen, X; Woiciechowsky, A; Raffegerst, S; Schendel, D; Kolb, HJ; Roskrow, M
    Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis
    BRITISH JOURNAL OF HAEMATOLOGY
    
    X. Chen et al., "Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis", BR J HAEM, 111(3), 2000, pp. 817-825
21. Trimble, LA; Kam, LW; Friedman, RS; Xu, Z; Lieberman, J
    CD3 zeta and CD28 down-modulation on CD8 T cells during viral infection
    BLOOD
    
    L.A. Trimble et al., "CD3 zeta and CD28 down-modulation on CD8 T cells during viral infection", BLOOD, 96(3), 2000, pp. 1021-1029
22. Alvarez-Vallina, L
    Targeted cell immunotherapy of human cancer: a promising approach that is extending its initial cell and molecular scope
    TUMOR TARGETING
    
    L. Alvarez-Vallina, "Targeted cell immunotherapy of human cancer: a promising approach that is extending its initial cell and molecular scope", TUMOR TARG, 4(4), 1999, pp. 225-234
23. Nolan, KF; Yun, CO; Akamatsu, Y; Murphy, JC; Leung, SO; Beecham, EJ; Junghans, RP
    Bypassing immunization: Optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA
    CLINICAL CANCER RESEARCH
    
    K.F. Nolan et al., "Bypassing immunization: Optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA", CLIN CANC R, 5(12), 1999, pp. 3928-3941
24. Bedenicki, I; Newton, DJ; Flanagan, BF; Johnson, PM; Rukavina, D; Christmas, SE
    Human decidualized endometrial T lymphocytes do not substantially down-regulate CD3 zeta
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
    
    I. Bedenicki et al., "Human decidualized endometrial T lymphocytes do not substantially down-regulate CD3 zeta", AM J REPROD, 41(4), 1999, pp. 245-252
25. Serrador, JM; Nieto, M; Sanchez-Madrid, F
    Cytoskeletal rearrangement during migration and activation of T lymphocytes
    TRENDS IN CELL BIOLOGY
    
    J.M. Serrador et al., "Cytoskeletal rearrangement during migration and activation of T lymphocytes", TR CELL BIO, 9(6), 1999, pp. 228-232
26. Reinhold, MI; Green, JM; Lindberg, FP; Ticchioni, M; Brown, EJ
    Cell spreading distinguishes the mechanism of augmentation of T cell activation by integrin-associated protein/CD47 and CD28
    INTERNATIONAL IMMUNOLOGY
    
    M.I. Reinhold et al., "Cell spreading distinguishes the mechanism of augmentation of T cell activation by integrin-associated protein/CD47 and CD28", INT IMMUNOL, 11(5), 1999, pp. 707-718
27. Gratama, JW; Zea, AH; Bolhuis, RLH; Ochoa, AC
    Restoration of expression of signal-transduction molecules in lymphocytes from patients with metastatic renal cell cancer after combination immunotherapy
    CANCER IMMUNOLOGY IMMUNOTHERAPY
    
    J.W. Gratama et al., "Restoration of expression of signal-transduction molecules in lymphocytes from patients with metastatic renal cell cancer after combination immunotherapy", CANCER IMMU, 48(5), 1999, pp. 263-269
28. Tsokos, GC; Liossis, SNC
    Immune cell signaling defects in lupus: activation, anergy and death
    IMMUNOLOGY TODAY
    
    G.C. Tsokos e S.N.C. Liossis, "Immune cell signaling defects in lupus: activation, anergy and death", IMMUNOL TOD, 20(3), 1999, pp. 119-124
29. Kennedy, JS; Raab, M; Rudd, CE
    Signaling scaffolds in immune cells
    CELL CALCIUM
    
    J.S. Kennedy et al., "Signaling scaffolds in immune cells", CELL CALC, 26(5), 1999, pp. 227-235
30. Davis, MM; Wulfing, C; Krummel, MF; Savage, PA; Xu, J; Sumen, C; Dustin, ML; Chien, YH
    Visualizing T-cell recognition
    COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
    
    M.M. Davis et al., "Visualizing T-cell recognition", COLD S HARB, 64, 1999, pp. 243-251
31. Kwon, ED; Foster, BA; Hurwitz, AA; Madias, C; Allison, JP; Greenberg, NM; Burg, MB
    Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    E.D. Kwon et al., "Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy", P NAS US, 96(26), 1999, pp. 15074-15079
32. Maccalli, C; Pisarra, P; Vegetti, C; Sensi, M; Parmiani, G; Anichini, A
    Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions
    JOURNAL OF IMMUNOLOGY
    
    C. Maccalli et al., "Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions", J IMMUNOL, 163(12), 1999, pp. 6912-6923
33. Zubiaur, M; Guirado, M; Terhorst, C; Malavasi, F; Sancho, J
    The CD3-gamma delta epsilon transducing module mediates CD38-induced protein-tyrosine kinase and mitogen-activated protein kinase activation in Jurkat T cells
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    M. Zubiaur et al., "The CD3-gamma delta epsilon transducing module mediates CD38-induced protein-tyrosine kinase and mitogen-activated protein kinase activation in Jurkat T cells", J BIOL CHEM, 274(29), 1999, pp. 20633-20642
34. ABO A
    UNDERSTANDING THE MOLECULAR-BASIS OF WISKOTT-ALDRICH-SYNDROME
    Cellular and molecular life sciences
    
    A. Abo, "UNDERSTANDING THE MOLECULAR-BASIS OF WISKOTT-ALDRICH-SYNDROME", Cellular and molecular life sciences, 54(10), 1998, pp. 1145-1153
35. TOSELLO AC; MARY F; AMIOT M; BERNARD A; MARY D
    ACTIVATION OF T-CELLS VIA CD55 - RECRUITMENT OF EARLY COMPONENTS OF THE CD3-TCR PATHWAY IS REQUIRED FOR IL-2 SECRETION
    Journal of inflammation
    
    A.C. Tosello et al., "ACTIVATION OF T-CELLS VIA CD55 - RECRUITMENT OF EARLY COMPONENTS OF THE CD3-TCR PATHWAY IS REQUIRED FOR IL-2 SECRETION", Journal of inflammation, 48(1), 1998, pp. 13-27
36. BUKOWSKI RM; RAYMAN P; UZZO R; BLOOM T; SANDSTROM K; PEEREBOOM D; OLENCKI T; BUDD GT; MCLAIN D; ELSON P; NOVICK A; FINKE JH
    SIGNAL-TRANSDUCTION ABNORMALITIES IN T-LYMPHOCYTES FROM PATIENTS WITHADVANCED RENAL-CARCINOMA - CLINICAL RELEVANCE AND EFFECTS OF CYTOKINETHERAPY
    Clinical cancer research
    
    R.M. Bukowski et al., "SIGNAL-TRANSDUCTION ABNORMALITIES IN T-LYMPHOCYTES FROM PATIENTS WITHADVANCED RENAL-CARCINOMA - CLINICAL RELEVANCE AND EFFECTS OF CYTOKINETHERAPY", Clinical cancer research, 4(10), 1998, pp. 2337-2347
37. XAVIER R; BRENNAN T; LI QQ; MCCORMACK C; SEED B
    MEMBRANE COMPARTMENTATION IS REQUIRED FOR EFFICIENT T-CELL ACTIVATION
    Immunity
    
    R. Xavier et al., "MEMBRANE COMPARTMENTATION IS REQUIRED FOR EFFICIENT T-CELL ACTIVATION", Immunity, 8(6), 1998, pp. 723-732
38. Moran, M; Miceli, MC
    Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: A role for lipid rafts in T cell activation
    IMMUNITY
    
    M. Moran e M.C. Miceli, "Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: A role for lipid rafts in T cell activation", IMMUNITY, 9(6), 1998, pp. 787-796
39. LINDAUER M; STANISLAWSKI T; HAUSSLER A; ANTUNES E; CELLARY A; HUBER C; THEOBALD M
    THE MOLECULAR-BASIS OF CANCER-IMMUNOTHERAPY BY CYTOTOXIC T-LYMPHOCYTES
    Journal of molecular medicine
    
    M. Lindauer et al., "THE MOLECULAR-BASIS OF CANCER-IMMUNOTHERAPY BY CYTOTOXIC T-LYMPHOCYTES", Journal of molecular medicine, 76(1), 1998, pp. 32-47
40. BISHARA A; AKER M; AMAR A; BRAUTBAR C; SCHLESINGER M; RABINOWITZ R; SLAVIN S; BANIYASH M
    ENHANCED LYMPHOID-CELL RECOVERY AFTER BONE-MARROW TRANSPLANTATION - CORRELATION WITH THE PRESENCE OF COSTIMULATORY ANTIBODIES IN SERUM
    Experimental hematology
    
    A. Bishara et al., "ENHANCED LYMPHOID-CELL RECOVERY AFTER BONE-MARROW TRANSPLANTATION - CORRELATION WITH THE PRESENCE OF COSTIMULATORY ANTIBODIES IN SERUM", Experimental hematology, 26(7), 1998, pp. 580-587
41. FITZERATTAS CJ; ESHHAR Z
    TYROSINE KINASE CHIMERAS FOR ANTIGEN-SELECTIVE T-BODY THERAPY
    Advanced drug delivery reviews
    
    C.J. Fitzerattas e Z. Eshhar, "TYROSINE KINASE CHIMERAS FOR ANTIGEN-SELECTIVE T-BODY THERAPY", Advanced drug delivery reviews, 31(1-2), 1998, pp. 171-182
42. ABKEN H; HOMBACH A; REINHOLD U; FERRONE S
    CAN COMBINED T-CELL-BASED AND ANTIBODY-BASED IMMUNOTHERAPY OUTSMART TUMOR-CELLS
    Immunology today
    
    H. Abken et al., "CAN COMBINED T-CELL-BASED AND ANTIBODY-BASED IMMUNOTHERAPY OUTSMART TUMOR-CELLS", Immunology today, 19(1), 1998, pp. 2-5
43. VONBONIN A; HUHN J; FLEISCHER B
    DIPEPTIDYL-PEPTIDASE IV CD26 ON T-CELLS - ANALYSIS OF AN ALTERNATIVE T-CELL ACTIVATION PATHWAY/
    Immunological reviews
    
    A. Vonbonin et al., "DIPEPTIDYL-PEPTIDASE IV CD26 ON T-CELLS - ANALYSIS OF AN ALTERNATIVE T-CELL ACTIVATION PATHWAY/", Immunological reviews, 161, 1998, pp. 43-53
44. STAVELEYOCARROLL K; SOTOMAYOR E; MONTGOMERY J; BORRELLO I; HWANG L; FEIN S; PARDOLL D; LEVITSKY H
    INDUCTION OF ANTIGEN-SPECIFIC T-CELL ANERGY - AN EARLY EVENT IN THE COURSE OF TUMOR PROGRESSION
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    K. Staveleyocarroll et al., "INDUCTION OF ANTIGEN-SPECIFIC T-CELL ANERGY - AN EARLY EVENT IN THE COURSE OF TUMOR PROGRESSION", Proceedings of the National Academy of Sciences of the United Statesof America, 95(3), 1998, pp. 1178-1183
45. WOODSIDE DG; WOOTEN DK; MCINTYRE BW
    ADENOSINE-DIPHOSPHATE (ADP)-RIBOSYLATION OF THE GUANOSINE TRIPHOSPHATASE (GTPASE) RHO IN RESTING PERIPHERAL-BLOOD HUMAN T-LYMPHOCYTES RESULTS IN PSEUDOPODIAL EXTENSION AND THE INHIBITION OF T-CELL ACTIVATION
    The Journal of experimental medicine
    
    D.G. Woodside et al., "ADENOSINE-DIPHOSPHATE (ADP)-RIBOSYLATION OF THE GUANOSINE TRIPHOSPHATASE (GTPASE) RHO IN RESTING PERIPHERAL-BLOOD HUMAN T-LYMPHOCYTES RESULTS IN PSEUDOPODIAL EXTENSION AND THE INHIBITION OF T-CELL ACTIVATION", The Journal of experimental medicine, 188(7), 1998, pp. 1211-1221
46. LOWINKROPF B; SHAPIRO VS; WEISS A
    CYTOSKELETAL POLARIZATION OF T-CELLS IS REGULATED BY AN IMMUNORECEPTOR TYROSINE-BASED ACTIVATION MOTIF-DEPENDENT MECHANISM
    The Journal of cell biology
    
    B. Lowinkropf et al., "CYTOSKELETAL POLARIZATION OF T-CELLS IS REGULATED BY AN IMMUNORECEPTOR TYROSINE-BASED ACTIVATION MOTIF-DEPENDENT MECHANISM", The Journal of cell biology, 140(4), 1998, pp. 861-871
47. ZEITLMANN L; KNORR T; KNOLL M; ROMEO C; SIRIM P; KOLANUS W
    T-CELL ACTIVATION-INDUCED BY NOVEL GAIN-OF-FUNCTION MUTANTS OF SYK AND ZAP-70
    The Journal of biological chemistry
    
    L. Zeitlmann et al., "T-CELL ACTIVATION-INDUCED BY NOVEL GAIN-OF-FUNCTION MUTANTS OF SYK AND ZAP-70", The Journal of biological chemistry, 273(25), 1998, pp. 15445-15452
48. ARNOULD T; KIM E; TSIOKAS L; JOCHIMSEN F; GRUNING W; CHANG JD; WALZ G
    THE POLYCYSTIC KIDNEY-DISEASE-1 GENE-PRODUCT MEDIATES PROTEIN-KINASE-C ALPHA-DEPENDENT AND C-JUN N-TERMINAL KINASE-DEPENDENT ACTIVATION OF THE TRANSCRIPTION FACTOR AP-1
    The Journal of biological chemistry
    
    T. Arnould et al., "THE POLYCYSTIC KIDNEY-DISEASE-1 GENE-PRODUCT MEDIATES PROTEIN-KINASE-C ALPHA-DEPENDENT AND C-JUN N-TERMINAL KINASE-DEPENDENT ACTIVATION OF THE TRANSCRIPTION FACTOR AP-1", The Journal of biological chemistry, 273(11), 1998, pp. 6013-6018
49. ZEA AH; OCHOA MT; GHOSH P; LONGO DL; ALVORD WG; VALDERRAMA L; FALABELLA R; HARVEY LK; SARAVIA N; MORENO LH; OCHOA AC
    CHANGES IN EXPRESSION OF SIGNAL-TRANSDUCTION PROTEINS IN T-LYMPHOCYTES OF PATIENTS WITH LEPROSY
    Infection and immunity
    
    A.H. Zea et al., "CHANGES IN EXPRESSION OF SIGNAL-TRANSDUCTION PROTEINS IN T-LYMPHOCYTES OF PATIENTS WITH LEPROSY", Infection and immunity, 66(2), 1998, pp. 499-504
50. VONBONIN A; EHRLICH S; FLEISCHER B
    THE TRANSMEMBRANE REGION OF CD2-ASSOCIATED SIGNAL-TRANSDUCING PROTEINS IS CRUCIAL FOR THE OUTCOME OF CD2-MEDIATED T-CELL ACTIVATION
    Immunology
    
    A. Vonbonin et al., "THE TRANSMEMBRANE REGION OF CD2-ASSOCIATED SIGNAL-TRANSDUCING PROTEINS IS CRUCIAL FOR THE OUTCOME OF CD2-MEDIATED T-CELL ACTIVATION", Immunology, 93(3), 1998, pp. 376-382
51. Garcia, GG; Miller, RA
    Increased Zap-70 association with CD3 zeta in CD4 T cells from old mice
    CELLULAR IMMUNOLOGY
    
    G.G. Garcia e R.A. Miller, "Increased Zap-70 association with CD3 zeta in CD4 T cells from old mice", CELL IMMUN, 190(2), 1998, pp. 91-100
52. BUGGINS AGS; HIRST WJR; PAGLIUCA A; MUFTI GJ
    VARIABLE EXPRESSION OF CD3-ZETA AND ASSOCIATED PROTEIN-TYROSINE KINASES IN LYMPHOCYTES FROM PATIENTS WITH MYELOID MALIGNANCIES
    British Journal of Haematology
    
    A.G.S. Buggins et al., "VARIABLE EXPRESSION OF CD3-ZETA AND ASSOCIATED PROTEIN-TYROSINE KINASES IN LYMPHOCYTES FROM PATIENTS WITH MYELOID MALIGNANCIES", British Journal of Haematology, 100(4), 1998, pp. 784-792
53. DEKONING J; KAYE JG
    REQUIREMENTS FOR DIFFERENTIATION OF AN IMMATURE CD4(-CELL LINE()8(+) T)
    Developmental immunology
    
    J. Dekoning e J.G. Kaye, "REQUIREMENTS FOR DIFFERENTIATION OF AN IMMATURE CD4(-CELL LINE()8(+) T)", Developmental immunology, 5(2), 1997, pp. 91-103
54. SCHARENBERG AM; KINET JP
    FC-EPSILON-RI AND THE FCR-BETA AMPLIFIER
    International archives of allergy and immunology
    
    A.M. Scharenberg e J.P. Kinet, "FC-EPSILON-RI AND THE FCR-BETA AMPLIFIER", International archives of allergy and immunology, 113(1-3), 1997, pp. 42-44
55. BECKER JC; TERHEYDEN P; BROCKER EB
    MOLECULAR-BASIS OF T-CELL DYSFUNCTION IN MELANOMA
    Melanoma research
    
    J.C. Becker et al., "MOLECULAR-BASIS OF T-CELL DYSFUNCTION IN MELANOMA", Melanoma research, 7, 1997, pp. 51-57
56. DAVE VP; CAO ZS; BROWNE C; ALARCON B; FERNANDEZMIGUEL G; LAFAILLE J; DELAHERA A; TONEGAWA S; KAPPES DJ
    CD3-DELTA DEFICIENCY ARRESTS DEVELOPMENT OF THE ALPHA-BETA BUT NOT THE GAMMA-DELTA T-CELL LINEAGE
    EMBO journal
    
    V.P. Dave et al., "CD3-DELTA DEFICIENCY ARRESTS DEVELOPMENT OF THE ALPHA-BETA BUT NOT THE GAMMA-DELTA T-CELL LINEAGE", EMBO journal, 16(6), 1997, pp. 1360-1370
57. DALL P; HEKELE A; BECKMANN MW; BENDER HG; HERRLICH P; PONTA H
    EFFICIENT LYSIS OF CD44V7 8-PRESENTING TARGET-CELLS BY GENETICALLY-ENGINEERED CYTOTOXIC T-LYMPHOCYTES - A MODEL FOR IMMUNOGENE THERAPY OF CERVICAL-CANCER/
    Gynecologic oncology
    
    P. Dall et al., "EFFICIENT LYSIS OF CD44V7 8-PRESENTING TARGET-CELLS BY GENETICALLY-ENGINEERED CYTOTOXIC T-LYMPHOCYTES - A MODEL FOR IMMUNOGENE THERAPY OF CERVICAL-CANCER/", Gynecologic oncology, 66(2), 1997, pp. 209-216
58. CORREA MR; OCHOA AC; GHOSH P; MIZOGUCHI H; HARVEY L; LONGO DL
    SEQUENTIAL DEVELOPMENT OF STRUCTURAL AND FUNCTIONAL ALTERATIONS IN T-CELLS FROM TUMOR-BEARING MICE
    The Journal of immunology
    
    M.R. Correa et al., "SEQUENTIAL DEVELOPMENT OF STRUCTURAL AND FUNCTIONAL ALTERATIONS IN T-CELLS FROM TUMOR-BEARING MICE", The Journal of immunology, 158(11), 1997, pp. 5292-5296
59. SALVADORI S; ZIER K
    GENE-THERAPY WITH MODIFIED TUMOR-CELLS ENABLES T-CELL ACTIVATION BY STIMULATING PATHWAYS REQUIRED FOR SIGNAL-TRANSDUCTION
    Cytokines and molecular therapy
    
    S. Salvadori e K. Zier, "GENE-THERAPY WITH MODIFIED TUMOR-CELLS ENABLES T-CELL ACTIVATION BY STIMULATING PATHWAYS REQUIRED FOR SIGNAL-TRANSDUCTION", Cytokines and molecular therapy, 2(3), 1996, pp. 171-175
60. TIAN H; LEMPICKI R; KING L; DONOGHUE E; SAMELSON LE; COHEN DI
    HIV ENVELOPE-DIRECTED SIGNALING ABERRANCIES AND CELL-DEATH OF CD4(-CELLS IN THE ABSENCE OF TCR CO-STIMULATION() T)
    International immunology
    
    H. Tian et al., "HIV ENVELOPE-DIRECTED SIGNALING ABERRANCIES AND CELL-DEATH OF CD4(-CELLS IN THE ABSENCE OF TCR CO-STIMULATION() T)", International immunology, 8(1), 1996, pp. 65-74
61. KIESSLING R; KONO K; PETERSSON M; WASSERMAN K
    IMMUNOSUPPRESSION IN HUMAN TUMOR-HOST INTERACTION - ROLE OF CYTOKINESAND ALTERATIONS IN SIGNAL-TRANSDUCING MOLECULES
    Perspectives in mathematical logic
    
    R. Kiessling et al., "IMMUNOSUPPRESSION IN HUMAN TUMOR-HOST INTERACTION - ROLE OF CYTOKINESAND ALTERATIONS IN SIGNAL-TRANSDUCING MOLECULES", Perspectives in mathematical logic, 18(2), 1996, pp. 227-242
62. LEVEY DL; SRIVASTAVA PK
    ALTERATIONS IN T-CELLS OF CANCER-BEARERS - WHENCE SPECIFICITY
    Immunology today
    
    D.L. Levey e P.K. Srivastava, "ALTERATIONS IN T-CELLS OF CANCER-BEARERS - WHENCE SPECIFICITY", Immunology today, 17(8), 1996, pp. 365-368
63. SALVADORI S; ZIER K
    MOLECULAR-BASIS OF T-CELL DYSFUNCTION IN CANCER IS INFLUENCED BY THE PARACRINE SECRETION OF TUMOR-DERIVED IL-2
    The Journal of immunology
    
    S. Salvadori e K. Zier, "MOLECULAR-BASIS OF T-CELL DYSFUNCTION IN CANCER IS INFLUENCED BY THE PARACRINE SECRETION OF TUMOR-DERIVED IL-2", The Journal of immunology, 156(8), 1996, pp. 2927-2932
64. WEISSENHORN W; ECK MJ; HARRISON SC; WILEY DC
    PHOSPHORYLATED T-CELL RECEPTOR XI-CHAIN AND ZAP70 TANDEM SH2 DOMAINS FORM A 1 3 COMPLEX IN-VITRO/
    European journal of biochemistry
    
    W. Weissenhorn et al., "PHOSPHORYLATED T-CELL RECEPTOR XI-CHAIN AND ZAP70 TANDEM SH2 DOMAINS FORM A 1 3 COMPLEX IN-VITRO/", European journal of biochemistry, 238(2), 1996, pp. 440-445
65. HULTEN MA; STACEY M; ARMSTRONG SJ
    DOES JUNK DNA REGULATE GENE-EXPRESSION IN HUMANS
    JCP. Clinical molecular pathology
    
    M.A. Hulten et al., "DOES JUNK DNA REGULATE GENE-EXPRESSION IN HUMANS", JCP. Clinical molecular pathology, 48(3), 1995, pp. 118-123
66. SHINKAI Y; MA A; CHENG HL; ALT FW
    CD3-EPSILON AND CD3-XI CYTOPLASMIC DOMAINS CAN INDEPENDENTLY GENERATESIGNALS FOR T-CELL DEVELOPMENT AND FUNCTION
    Immunity
    
    Y. Shinkai et al., "CD3-EPSILON AND CD3-XI CYTOPLASMIC DOMAINS CAN INDEPENDENTLY GENERATESIGNALS FOR T-CELL DEVELOPMENT AND FUNCTION", Immunity, 2(4), 1995, pp. 401-411
67. YANAGI S; KUROSAKI T; YAMAMURA H
    THE STRUCTURE AND FUNCTION OF NONRECEPTOR TYROSINE KINASE P72(SYK) EXPRESSED IN HEMATOPOIETIC-CELLS
    Cellular signalling
    
    S. Yanagi et al., "THE STRUCTURE AND FUNCTION OF NONRECEPTOR TYROSINE KINASE P72(SYK) EXPRESSED IN HEMATOPOIETIC-CELLS", Cellular signalling, 7(3), 1995, pp. 185-193
68. HAUBER I; FISCHER MB; MARIS M; EIBL MM
    REDUCED IL-2 EXPRESSION UPON ANTIGEN STIMULATION IS ACCOMPANIED BY DEFICIENT IL-9 GENE-EXPRESSION IN T-CELLS OF PATIENTS WITH CVID
    Scandinavian journal of immunology
    
    I. Hauber et al., "REDUCED IL-2 EXPRESSION UPON ANTIGEN STIMULATION IS ACCOMPANIED BY DEFICIENT IL-9 GENE-EXPRESSION IN T-CELLS OF PATIENTS WITH CVID", Scandinavian journal of immunology, 41(3), 1995, pp. 215-219
69. ZENNER G; ZURHAUSEN JD; BURN P; MUSTELIN T
    TOWARDS UNRAVELING THE COMPLEXITY OF T-CELL SIGNAL-TRANSDUCTION
    BioEssays
    
    G. Zenner et al., "TOWARDS UNRAVELING THE COMPLEXITY OF T-CELL SIGNAL-TRANSDUCTION", BioEssays, 17(11), 1995, pp. 967-975
70. MIGITA K; EGUCHI K; KAWABE Y; TSUKADA T; ICHINOSE Y; NAGATAKI S
    DEFECTIVE TCR-MEDIATED SIGNALING IN ANERGIC T-CELLS
    The Journal of immunology
    
    K. Migita et al., "DEFECTIVE TCR-MEDIATED SIGNALING IN ANERGIC T-CELLS", The Journal of immunology, 155(11), 1995, pp. 5083-5087
71. STURMHOFEL K; BRANDO C; MARTINON F; SHEVACH EM; COLIGAN JE
    ANTIGEN-INDEPENDENT, INTEGRIN-MEDIATED T-CELL ACTIVATION
    The Journal of immunology
    
    K. Sturmhofel et al., "ANTIGEN-INDEPENDENT, INTEGRIN-MEDIATED T-CELL ACTIVATION", The Journal of immunology, 154(5), 1995, pp. 2104-2111
72. TARTOUR E; LATOUR S; MATHIOT C; THIOUNN N; MOSSERI V; JOYEUX I; DENGHIEN CD; LEE RS; DEBRE B; FRIDMAN WH
    VARIABLE EXPRESSION OF CD3-ZETA CHAIN IN TUMOR-INFILTRATING LYMPHOCYTES (TIL) DERIVED FROM RENAL-CELL CARCINOMA - RELATIONSHIP WITH TIL PHENOTYPE AND FUNCTION
    International journal of cancer
    
    E. Tartour et al., "VARIABLE EXPRESSION OF CD3-ZETA CHAIN IN TUMOR-INFILTRATING LYMPHOCYTES (TIL) DERIVED FROM RENAL-CELL CARCINOMA - RELATIONSHIP WITH TIL PHENOTYPE AND FUNCTION", International journal of cancer, 63(2), 1995, pp. 205-212
73. MATSUDA M; PETERSSON M; LENKEI R; TAUPIN JL; MAGNUSSON I; MELLSTEDT H; ANDERSON P; KIESSLING R
    ALTERATIONS IN THE SIGNAL-TRANSDUCING MOLECULES OF T-CELLS AND NK CELLS IN COLORECTAL TUMOR-INFILTRATING, GUT MUCOSAL AND PERIPHERAL LYMPHOCYTES - CORRELATION WITH THE STAGE OF THE DISEASE
    International journal of cancer
    
    M. Matsuda et al., "ALTERATIONS IN THE SIGNAL-TRANSDUCING MOLECULES OF T-CELLS AND NK CELLS IN COLORECTAL TUMOR-INFILTRATING, GUT MUCOSAL AND PERIPHERAL LYMPHOCYTES - CORRELATION WITH THE STAGE OF THE DISEASE", International journal of cancer, 61(6), 1995, pp. 765-772
74. BALDARI CT; DISOMMA MM; MILIA E; BERGMAN M; TELFORD JL
    INTERACTIONS BETWEEN THE TYROSINE KINASES P56LCK, P59FYN AND P50CSK IN CD4 SIGNALING IN T-CELLS
    European Journal of Immunology
    
    C.T. Baldari et al., "INTERACTIONS BETWEEN THE TYROSINE KINASES P56LCK, P59FYN AND P50CSK IN CD4 SIGNALING IN T-CELLS", European Journal of Immunology, 25(4), 1995, pp. 919-925
75. AOE T; GOTO S; OHNO H; SAITO T
    DIFFERENT CYTOPLASMIC STRUCTURE OF THE CD3-ZETA FAMILY DIMER MODULATES THE ACTIVATION SIGNAL AND FUNCTION OF T-CELLS
    International immunology
    
    T. Aoe et al., "DIFFERENT CYTOPLASMIC STRUCTURE OF THE CD3-ZETA FAMILY DIMER MODULATES THE ACTIVATION SIGNAL AND FUNCTION OF T-CELLS", International immunology, 6(11), 1994, pp. 1671-1679
76. TAKAI S; KASAMA M; YAMADA K; KAI N; HIRAYAMA N; NAMIKI H; TANIYAMA T
    HUMAN HIGH-AFFINITY FC-GAMMA-RI (CD64) GENE MAPPED TO CHROMOSOME 1Q21.2-Q21.3 BY FLUORESCENCE IN-SITU HYBRIDIZATION
    Human genetics
    
    S. Takai et al., "HUMAN HIGH-AFFINITY FC-GAMMA-RI (CD64) GENE MAPPED TO CHROMOSOME 1Q21.2-Q21.3 BY FLUORESCENCE IN-SITU HYBRIDIZATION", Human genetics, 93(1), 1994, pp. 13-15
77. RUDD CE; JANSSEN O; CAI YC; DASILVA AJ; RAAB M; PRASAD KVS
    2-STEP TCR-ZETA CD3-CD4 AND CD28 SIGNALING IN T-CELLS - SH2/SH3 DOMAINS, PROTEIN-TYROSINE AND LIPID KINASES/
    Immunology today
    
    C.E. Rudd et al., "2-STEP TCR-ZETA CD3-CD4 AND CD28 SIGNALING IN T-CELLS - SH2/SH3 DOMAINS, PROTEIN-TYROSINE AND LIPID KINASES/", Immunology today, 15(5), 1994, pp. 225-234
78. KOYASU S; TSE AGD; MOINGEON P; HUSSEY RE; MILDONIAN A; HANNISIAN J; CLAYTON LK; REINHERZ EL
    DELINEATION OF A T-CELL ACTIVATION MOTIF REQUIRED FOR BINDING OF PROTEIN-TYROSINE KINASES CONTAINING TANDEM SH2 DOMAINS
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    S. Koyasu et al., "DELINEATION OF A T-CELL ACTIVATION MOTIF REQUIRED FOR BINDING OF PROTEIN-TYROSINE KINASES CONTAINING TANDEM SH2 DOMAINS", Proceedings of the National Academy of Sciences of the United Statesof America, 91(14), 1994, pp. 6693-6697
79. MORITZ D; WELS W; MATTERN J; GRONER B
    CYTOTOXIC T-LYMPHOCYTES WITH A GRAFTED RECOGNITION SPECIFICITY FOR ERBB2-EXPRESSING TUMOR-CELLS
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    D. Moritz et al., "CYTOTOXIC T-LYMPHOCYTES WITH A GRAFTED RECOGNITION SPECIFICITY FOR ERBB2-EXPRESSING TUMOR-CELLS", Proceedings of the National Academy of Sciences of the United Statesof America, 91(10), 1994, pp. 4318-4322
80. ORCHANSKY PL; TEH HS
    ACTIVATION-INDUCED CELL-DEATH IN PROLIFERATING T-CELLS IS ASSOCIATED WITH ALTERED TYROSINE PHOSPHORYLATION OF TCR CD3 SUBUNITS/
    The Journal of immunology
    
    P.L. Orchansky e H.S. Teh, "ACTIVATION-INDUCED CELL-DEATH IN PROLIFERATING T-CELLS IS ASSOCIATED WITH ALTERED TYROSINE PHOSPHORYLATION OF TCR CD3 SUBUNITS/", The Journal of immunology, 153(2), 1994, pp. 615-622
81. SALVADORI S; GANSBACHER B; PIZZIMENTI AM; ZIER KS
    ABNORMAL SIGNAL-TRANSDUCTION BY T-CELLS OF MICE WITH PARENTAL TUMORS IS NOT SEEN IN MICE BEARING IL-2-SECRETING TUMORS
    The Journal of immunology
    
    S. Salvadori et al., "ABNORMAL SIGNAL-TRANSDUCTION BY T-CELLS OF MICE WITH PARENTAL TUMORS IS NOT SEEN IN MICE BEARING IL-2-SECRETING TUMORS", The Journal of immunology, 153(11), 1994, pp. 5176-5182
82. VANOERS NSC; TEH SJ; IRVING BA; TIONG J; WEISS A; TEH HS
    PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FORTHE MURINE T-CELL RECEPTOR ZETA-CHAIN
    Journal of immunological methods
    
    N.S.C. Vanoers et al., "PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FORTHE MURINE T-CELL RECEPTOR ZETA-CHAIN", Journal of immunological methods, 170(2), 1994, pp. 261-268
83. KOYASU S
    CD3(-BETA-TCR(+)CD4(-)CD8(-) AND GAMMA-DELTA-TCR(+)CD4(-)CD8(-) CELLS()CD16(+)NK1.1(+)B220(+) LARGE GRANULAR LYMPHOCYTES ARISE FROM BOTH ALPHA)
    The Journal of experimental medicine
    
    S. Koyasu, "CD3(-BETA-TCR(+)CD4(-)CD8(-) AND GAMMA-DELTA-TCR(+)CD4(-)CD8(-) CELLS()CD16(+)NK1.1(+)B220(+) LARGE GRANULAR LYMPHOCYTES ARISE FROM BOTH ALPHA)", The Journal of experimental medicine, 179(6), 1994, pp. 1957-1972
84. KANAKARAJ P; DUCKWORTH B; AZZONI L; KAMOUN M; CANTLEY LC; PERUSSIA B
    PHOSPHATIDYLINOSITOL-3 KINASE ACTIVATION-INDUCED UPON FC-GAMMA-RIIIA-LIGAND INTERACTION
    The Journal of experimental medicine
    
    P. Kanakaraj et al., "PHOSPHATIDYLINOSITOL-3 KINASE ACTIVATION-INDUCED UPON FC-GAMMA-RIIIA-LIGAND INTERACTION", The Journal of experimental medicine, 179(2), 1994, pp. 551-558
85. CHU KT; LITTMAN DR
    REQUIREMENT FOR KINASE-ACTIVITY OF CD4-ASSOCIATED P56(LCK) IN ANTIBODY-TRIGGERED T-CELL SIGNAL-TRANSDUCTION
    The Journal of biological chemistry
    
    K.T. Chu e D.R. Littman, "REQUIREMENT FOR KINASE-ACTIVITY OF CD4-ASSOCIATED P56(LCK) IN ANTIBODY-TRIGGERED T-CELL SIGNAL-TRANSDUCTION", The Journal of biological chemistry, 269(39), 1994, pp. 24095-24101
86. EGERTON M; SAMELSON LE
    BIOCHEMICAL-CHARACTERIZATION OF VALOSIN-CONTAINING PROTEIN, A PROTEIN-TYROSINE KINASE SUBSTRATE IN HEMATOPOIETIC-CELLS
    The Journal of biological chemistry
    
    M. Egerton e L.E. Samelson, "BIOCHEMICAL-CHARACTERIZATION OF VALOSIN-CONTAINING PROTEIN, A PROTEIN-TYROSINE KINASE SUBSTRATE IN HEMATOPOIETIC-CELLS", The Journal of biological chemistry, 269(15), 1994, pp. 11435-11441
87. AOE T; OHNO H; SONTA S; SAITO T
    FUNCTIONAL INACTIVATION OF THE CD3-ZETA CHAIN IN A T-CELL HYBRIDOMA BY IN-VITRO GENE TARGETING
    International immunology
    
    T. Aoe et al., "FUNCTIONAL INACTIVATION OF THE CD3-ZETA CHAIN IN A T-CELL HYBRIDOMA BY IN-VITRO GENE TARGETING", International immunology, 5(7), 1993, pp. 725-733
88. LIU CP; UEDA R; SHE JA; SANCHO J; WANG BP; WEDDELL G; LORING J; KURAHARA C; DUDLEY EC; HAYDAY A; TERHORST C; HUANG M
    ABNORMAL T-CELL DEVELOPMENT IN CD3-ZETA- - MUTANT MICE AND IDENTIFICATION OF A NOVEL T-CELL POPULATION IN THE INTESTINE/
    EMBO journal
    
    C.P. Liu et al., "ABNORMAL T-CELL DEVELOPMENT IN CD3-ZETA- - MUTANT MICE AND IDENTIFICATION OF A NOVEL T-CELL POPULATION IN THE INTESTINE/", EMBO journal, 12(12), 1993, pp. 4863-4875
89. OHNO H; AOE T; TAKI S; KITAMURA D; ISHIDA Y; RAJEWSKY K; SAITO T
    DEVELOPMENTAL AND FUNCTIONAL IMPAIRMENT OF T-CELLS IN MICE LACKING CD3-ZETA CHAINS
    EMBO journal
    
    H. Ohno et al., "DEVELOPMENTAL AND FUNCTIONAL IMPAIRMENT OF T-CELLS IN MICE LACKING CD3-ZETA CHAINS", EMBO journal, 12(11), 1993, pp. 4357-4366
90. XU H; LITTMAN DR
    A KINASE-INDEPENDENT FUNCTION OF LCK IN POTENTIATING ANTIGEN-SPECIFICT-CELL ACTIVATION
    Cell
    
    H. Xu e D.R. Littman, "A KINASE-INDEPENDENT FUNCTION OF LCK IN POTENTIATING ANTIGEN-SPECIFICT-CELL ACTIVATION", Cell, 74(4), 1993, pp. 633-643
91. KOLANUS W; ROMEO C; SEED B
    T-CELL ACTIVATION BY CLUSTERED TYROSINE KINASES
    Cell
    
    W. Kolanus et al., "T-CELL ACTIVATION BY CLUSTERED TYROSINE KINASES", Cell, 74(1), 1993, pp. 171-183
92. MOLINA TJ; BACHMANN MF; KUNDIG TM; ZINKERNAGEL RM; MAK TW
    PERIPHERAL T-CELLS IN MICE LACKING P56(LCK) DO NOT EXPRESS SIGNIFICANT ANTIVIRAL EFFECTOR FUNCTIONS
    The Journal of immunology
    
    T.J. Molina et al., "PERIPHERAL T-CELLS IN MICE LACKING P56(LCK) DO NOT EXPRESS SIGNIFICANT ANTIVIRAL EFFECTOR FUNCTIONS", The Journal of immunology, 151(2), 1993, pp. 699-706
93. HUBERT P; DEBRE P; BOUMSELL L; BISMUTH G
    TYROSINE PHOSPHORYLATION AND ASSOCIATION WITH PHOSPHOLIPASE-C-GAMMA-11 OF THE GAP-ASSOCIATED 62-KD PROTEIN AFTER CD2 STIMULATION OF JURKATT-CELL
    The Journal of experimental medicine
    
    P. Hubert et al., "TYROSINE PHOSPHORYLATION AND ASSOCIATION WITH PHOSPHOLIPASE-C-GAMMA-11 OF THE GAP-ASSOCIATED 62-KD PROTEIN AFTER CD2 STIMULATION OF JURKATT-CELL", The Journal of experimental medicine, 178(5), 1993, pp. 1587-1596
94. VIVIER E; DASILVA AJ; ACKERLY M; LEVINE H; RUDD CE; ANDERSON P
    ASSOCIATION OF A 70-KDA TYROSINE PHOSPHOPROTEIN WITH THE CD16-ZETA-GAMMA COMPLEX EXPRESSED IN HUMAN NATURAL-KILLER-CELLS
    European Journal of Immunology
    
    E. Vivier et al., "ASSOCIATION OF A 70-KDA TYROSINE PHOSPHOPROTEIN WITH THE CD16-ZETA-GAMMA COMPLEX EXPRESSED IN HUMAN NATURAL-KILLER-CELLS", European Journal of Immunology, 23(8), 1993, pp. 1872-1876
95. RINCON M; TUGORES A; DELANDAZURI MO; LOPEZBOTET M
    COSTIMULATION OF CAMP AND PROTEIN-KINASE-C PATHWAYS INHIBITS THE CD3-DEPENDENT T-CELL ACTIVATION AND LEADS TO A PERSISTENT EXPRESSION OF THE AP-1 TRANSCRIPTION FACTOR
    Cellular immunology
    
    M. Rincon et al., "COSTIMULATION OF CAMP AND PROTEIN-KINASE-C PATHWAYS INHIBITS THE CD3-DEPENDENT T-CELL ACTIVATION AND LEADS TO A PERSISTENT EXPRESSION OF THE AP-1 TRANSCRIPTION FACTOR", Cellular immunology, 149(2), 1993, pp. 343-356